These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 7757974)

  • 21. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia.
    Stegmaier K; Takeuchi S; Golub TR; Bohlander SK; Bartram CR; Koeffler HP
    Cancer Res; 1996 Mar; 56(6):1413-7. PubMed ID: 8640833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation and expression analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in pituitary tumors.
    Takeuchi S; Koeffler HP; Hinton DR; Miyoshi I; Melmed S; Shimon I
    J Endocrinol; 1998 May; 157(2):337-41. PubMed ID: 9659297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of the INK4 family of genes in prostate carcinomas.
    Park DJ; Wilczynski SP; Pham EY; Miller CW; Koeffler HP
    J Urol; 1997 May; 157(5):1995-9. PubMed ID: 9112579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
    Zariwala M; Xiong Y
    Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
    Zariwala M; Liu E; Xiong Y
    Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
    Barbareschi M
    Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
    Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y; Sklar GN; Borkowski A; Kyprianou N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effect of extremely low frequency electromagnetic fields on cyclin-dependent kinase 4 inhibitor gene p18(INK4C) in electric energy workers.
    Erdal N; Erdal ME; Gürgül S
    Arch Med Res; 2005; 36(2):120-3. PubMed ID: 15847943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer.
    Shin JY; Kim HS; Lee KS; Kim J; Park JB; Won MH; Chae SW; Choi YH; Choi KC; Park YE; Lee JY
    Exp Mol Med; 2000 Jun; 32(2):79-83. PubMed ID: 10926119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a polymorphism in the coding region of the p27Kip1 gene.
    Cavé H; Martin E; Devaux I; Grandchamp B
    Ann Genet; 1995; 38(2):108. PubMed ID: 7486826
    [No Abstract]   [Full Text] [Related]  

  • 34. Absence of p18 mutations or deletions in lymphoid malignancies.
    Otsuki T; Jaffe ES; Wellmann A; Kumar S; Condron KS; Raffeld M
    Leukemia; 1996 Feb; 10(2):356-60. PubMed ID: 8637248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of the p15, p16,and p18 genes in osteosarcoma.
    Miller CW; Aslo A; Campbell MJ; Kawamata N; Lampkin BC; Koeffler HP
    Cancer Genet Cytogenet; 1996 Feb; 86(2):136-42. PubMed ID: 8603340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of the p16 (MTS1) gene in testicular, ovarian, and endometrial malignancies.
    Hatta Y; Hirama T; Takeuchi S; Lee E; Pham E; Miller CW; Strohmeyer T; Wilczynski SP; Melmed S; Koeffler HP
    J Urol; 1995 Nov; 154(5):1954-7. PubMed ID: 7563391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells.
    Komata T; Kanzawa T; Takeuchi H; Germano IM; Schreiber M; Kondo Y; Kondo S
    Br J Cancer; 2003 Apr; 88(8):1277-80. PubMed ID: 12698196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
    Southgate J; Proffitt J; Roberts P; Smith B; Selby P
    Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p27 and leukemia: cell cycle and beyond.
    Roy A; Banerjee S
    J Cell Physiol; 2015 Mar; 230(3):504-9. PubMed ID: 25205053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis of the p27(kip1) gene in hepatocellular carcinoma.
    Chen TC; Ng KF; Lien JM; Jeng LB; Chen MF; Hsieh LL
    Cancer Lett; 2000 May; 153(1-2):169-73. PubMed ID: 10779646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.